• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性 COVID-19 住院患者的严重精神疾病与院内死亡率:日本大型数据库分析。

Serious mental illness and in-hospital mortality among hospitalized patients with acute COVID-19: A large-database analysis in Japan.

机构信息

University of Tsukuba School of Medicine, Ibaraki, Japan; Tokyo Foundation for Policy Research, Minato-ku, Tokyo, Japan.

University of Nevada School of Medicine, Reno, USA.

出版信息

Gen Hosp Psychiatry. 2023 May-Jun;82:1-6. doi: 10.1016/j.genhosppsych.2023.01.014. Epub 2023 Feb 3.

DOI:10.1016/j.genhosppsych.2023.01.014
PMID:36868102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9894824/
Abstract

OBJECTIVE

The association of serious mental illness (affective or non-affective psychotic disorders) with higher mortality in patients infected with acute coronavirus disease 2019 (COVID-19) has been suggested. Although this association remains significant after adjusting for medical comorbidities in previous studies, admission clinical status and treatment modalities should be considered as important confounding factors.

METHODS

We aimed to assess whether serious mental illness is associated with in-hospital mortality, in patients with COVID-19 by adjusting for comorbidities, admission clinical status, and treatment modalities. Our nationwide cohort in Japan included consecutive patients admitted to 438 acute care hospitals for laboratory-confirmed acute COVID-19 from January 1, 2020 to November 30, 2021.

RESULTS

Of 67,348 hospitalized patients (mean [standard deviation] age, 54 [18.6] years; 3891 [53.0%] female), 2524 patients (3.75%) had serious mental illness. In-hospital mortality was 282/2524 (11.17%) among patients with serious mental illness, while it was 2118/64,824 (3.27%) in other patients. In the fully adjusted model, serious mental illness was significantly associated with in-hospital mortality (odds ratio, 1.49; 95% CI, 1.27-1.72). E-value analysis confirmed the robustness of the results.

CONCLUSION

Serious mental illness remains a risk for mortality in acute COVID-19 after adjusting for comorbidities, admission clinical status, and treatment modalities. Vaccination, diagnosis, early assessment and treatment should be prioritized for this vulnerable group.

摘要

目的

已有研究表明,严重精神疾病(情感或非情感性精神病障碍)与急性 2019 冠状病毒病(COVID-19)感染患者的死亡率升高有关。尽管在既往研究中,通过调整合并症后,这种关联仍然具有统计学意义,但入院临床状况和治疗方式应被视为重要的混杂因素。

方法

我们旨在通过调整合并症、入院临床状况和治疗方式,评估严重精神疾病是否与 COVID-19 患者的住院死亡率相关。我们在日本的全国性队列研究纳入了 2020 年 1 月 1 日至 2021 年 11 月 30 日期间因实验室确诊的急性 COVID-19 而入住 438 家急性护理医院的连续患者。

结果

在 67348 例住院患者中(平均[标准差]年龄为 54[18.6]岁;3891[53.0%]为女性),2524 例(3.75%)患有严重精神疾病。在严重精神疾病患者中,住院死亡率为 282/2524(11.17%),而在其他患者中为 2118/64824(3.27%)。在完全调整模型中,严重精神疾病与住院死亡率显著相关(比值比,1.49;95%置信区间,1.27-1.72)。E 值分析证实了结果的稳健性。

结论

在调整合并症、入院临床状况和治疗方式后,严重精神疾病仍然是急性 COVID-19 患者死亡的一个危险因素。应优先为这一脆弱群体接种疫苗、诊断、早期评估和治疗。

相似文献

1
Serious mental illness and in-hospital mortality among hospitalized patients with acute COVID-19: A large-database analysis in Japan.急性 COVID-19 住院患者的严重精神疾病与院内死亡率:日本大型数据库分析。
Gen Hosp Psychiatry. 2023 May-Jun;82:1-6. doi: 10.1016/j.genhosppsych.2023.01.014. Epub 2023 Feb 3.
2
Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State-wide Psychiatric Hospital System.在纽约州一家精神科医院系统中,长期住院的严重精神疾病患者使用精神药物与 COVID-19 感染风险之间的关联。
JAMA Netw Open. 2022 May 2;5(5):e2210743. doi: 10.1001/jamanetworkopen.2022.10743.
3
Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study.韩国精神疾病与新冠病毒易感性及临床结局之间的关联:一项全国性队列研究。
Lancet Psychiatry. 2020 Dec;7(12):1025-1031. doi: 10.1016/S2215-0366(20)30421-1. Epub 2020 Sep 17.
4
Hospitalization, Mechanical Ventilation, and Mortality After COVID-19 Among Adults With or Without Serious Mental Illness.新冠肺炎患者中有或无严重精神疾病者的住院、机械通气和死亡率。
Psychiatr Serv. 2022 Mar 1;73(3):335-338. doi: 10.1176/appi.ps.202100151. Epub 2021 Jul 29.
5
Risk of COVID-19 diagnosis and death in patients with mental illness: a cohort study.精神疾病患者 COVID-19 诊断和死亡风险:一项队列研究。
Epidemiol Psychiatr Sci. 2021 Oct 14;30:e68. doi: 10.1017/S2045796021000597.
6
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
7
Risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID-19 mortality in people with pre-existing mental disorders: an umbrella review.患有精神障碍的人群中 SARS-CoV-2 感染、重症 COVID-19 疾病和 COVID-19 死亡率的风险:伞式综述。
BMC Psychiatry. 2023 Mar 20;23(1):181. doi: 10.1186/s12888-023-04641-y.
8
Patient and Hospital Factors Associated With Differences in Mortality Rates Among Black and White US Medicare Beneficiaries Hospitalized With COVID-19 Infection.与 COVID-19 感染住院的美国医疗保险受益的黑人和白人患者死亡率差异相关的患者和医院因素。
JAMA Netw Open. 2021 Jun 1;4(6):e2112842. doi: 10.1001/jamanetworkopen.2021.12842.
9
Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.与 SARS-CoV-2 谱系 B.1.1.7 相关的在英国的死亡率和重症监护病房入院率:一项观察性队列研究。
Lancet Infect Dis. 2021 Nov;21(11):1518-1528. doi: 10.1016/S1473-3099(21)00318-2. Epub 2021 Jun 23.
10
Trends in Patient Characteristics and COVID-19 In-Hospital Mortality in the United States During the COVID-19 Pandemic.美国在 COVID-19 大流行期间患者特征和 COVID-19 院内死亡率的趋势。
JAMA Netw Open. 2021 May 3;4(5):e218828. doi: 10.1001/jamanetworkopen.2021.8828.

引用本文的文献

1
Effectiveness of COVID-19 Vaccines in People with Severe Mental Illness: A Systematic Review and Meta-Analysis.新冠疫苗对重症精神疾病患者的有效性:一项系统评价与荟萃分析
Vaccines (Basel). 2024 Sep 18;12(9):1064. doi: 10.3390/vaccines12091064.
2
COVID-19 risk, course and outcome in people with mental disorders: a systematic review and meta-analyses.COVID-19 风险、病程和结局在精神障碍患者中的研究:系统综述和荟萃分析。
Epidemiol Psychiatr Sci. 2023 Oct 20;32:e61. doi: 10.1017/S2045796023000719.

本文引用的文献

1
COVID-19 and severe mental illness in Israel: testing, infection, hospitalization, mortality and vaccination rates in a countrywide study.COVID-19 与以色列严重精神疾病:全国性研究中的检测、感染、住院、死亡率和疫苗接种率。
Mol Psychiatry. 2022 Jul;27(7):3107-3114. doi: 10.1038/s41380-022-01562-2. Epub 2022 Apr 22.
2
Mortality from coronavirus disease 2019 (Covid-19) in patients with schizophrenia: A systematic review, meta-analysis and meta-regression.2019 年冠状病毒病(COVID-19)患者中精神分裂症患者的死亡率:系统评价、荟萃分析和荟萃回归。
Gen Hosp Psychiatry. 2022 Mar-Apr;75:61-67. doi: 10.1016/j.genhosppsych.2022.01.010. Epub 2022 Feb 4.
3
COVID-19-Related Mortality Risk in People With Severe Mental Illness: A Systematic and Critical Review.严重精神疾病患者中与COVID-19相关的死亡风险:一项系统的批判性综述。
Front Psychiatry. 2022 Jan 13;12:798554. doi: 10.3389/fpsyt.2021.798554. eCollection 2021.
4
Association between Nafamostat Mesylate and In-Hospital Mortality in Patients with Coronavirus Disease 2019: A Multicenter Observational Study.甲磺酸萘莫司他与2019冠状病毒病患者院内死亡率的关联:一项多中心观察性研究
J Clin Med. 2021 Dec 26;11(1):116. doi: 10.3390/jcm11010116.
5
Comparison of patient characteristics and in-hospital mortality between patients with COVID-19 in 2020 and those with influenza in 2017-2020: a multicenter, retrospective cohort study in Japan.2020年新型冠状病毒肺炎患者与2017 - 2020年流感患者的特征及院内死亡率比较:日本一项多中心回顾性队列研究
Lancet Reg Health West Pac. 2022 Mar;20:100365. doi: 10.1016/j.lanwpc.2021.100365. Epub 2022 Jan 2.
6
Disparities in COVID-19 infection, hospitalisation and death in people with schizophrenia, bipolar disorder, and major depressive disorder: a cohort study of the UK Biobank.精神分裂症、双相情感障碍和重度抑郁症患者 COVID-19 感染、住院和死亡的差异:英国生物银行的队列研究。
Mol Psychiatry. 2022 Feb;27(2):1248-1255. doi: 10.1038/s41380-021-01344-2. Epub 2021 Dec 7.
7
Comorbid medical conditions are a key factor to understand the relationship between psychiatric disorders and COVID-19-related mortality: Results from 49,089 COVID-19 inpatients.合并症是理解精神疾病与新冠病毒疾病相关死亡率之间关系的关键因素:来自49089名新冠病毒疾病住院患者的结果
Mol Psychiatry. 2022 Mar;27(3):1278-1280. doi: 10.1038/s41380-021-01393-7. Epub 2021 Nov 26.
8
Analysis of COVID-19 Infection and Mortality Among Patients With Psychiatric Disorders, 2020.2020 年,精神障碍患者 COVID-19 感染与死亡率分析。
JAMA Netw Open. 2021 Nov 1;4(11):e2134969. doi: 10.1001/jamanetworkopen.2021.34969.
9
Association Between Antipsychotic Use and COVID-19 Mortality Among People With Serious Mental Illness.抗精神病药物的使用与严重精神疾病患者 COVID-19 死亡率之间的关联。
JAMA Psychiatry. 2021 Dec 1;78(12):1391-1393. doi: 10.1001/jamapsychiatry.2021.2503.
10
Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries: A Systematic Review and Meta-analysis.7 个国家的 COVID-19 患者心理健康障碍与死亡率之间的关联:系统评价和荟萃分析。
JAMA Psychiatry. 2021 Nov 1;78(11):1208-1217. doi: 10.1001/jamapsychiatry.2021.2274.